As in the case of therapeutic approaches that target TGF-β in cancers, TGFBI inhibition may stimulate or suppress tumor growth, although several reports indicate that TGFBI promotes the growth of gastrointestinal tumors (Table 1). This evidence concerns the gene TGFB1 and digestive system neoplasm.